CMV remains an area of huge unmet medical need. Despite decades of research, no CMV vaccine has been approved to date, underscoring the importance of these new discoveries COPENHAGEN, Denmark, ...
Evaxion's AI-ImmunologyTM platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program ...
Investing.com -- Evaxion Biotech AS (NASDAQ:EVAX) stock surged 10.6% on Thursday after the clinical-stage TechBio company announced significant progress in its cytomegalovirus (CMV) vaccine program, ...
NEW YORK, Nov. 13, 2025 /PRNewswire/ -- IAB Tech Lab, the global digital advertising technical standard-setting body, today announced the release of Agentic RTB Framework (ARTF) v1.0 for public ...
President Donald Trump drew criticism from those within his "Make America Great Again" base after he reinvigorated debate on one of his party's most controversial issues: H-1B visas. The visas allow U ...
Mayor Eric Adams announced plans Friday to reconfigure staffing for B-HEARD, the pilot program launched in 2021 that offers a non-police response to some 911 mental health calls. The overhaul comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback